The FADS2 gene is considered to be the likely central gene that regulates the effects of n-3 PUFAs on the risk of IBD, implying that desaturation steps in fatty acid metabolism may have a crucial role in the association between n-3 PUFAs and IBD. This evidence concerns the gene FADS2 and inflammatory bowel disease.